{"disease":{"id":"mutant-high-grade-glioma","name":"mutant high grade glioma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03434262","title":"SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false},{"nct_id":"NCT05375318","title":"BIOhabitats: Biological Validation of Vascular Habitats Within Astrocytoma Grade 4 at Molecular, Cellular, and Histopathological Levels","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Juan M Garcia-Gomez","has_results":false},{"nct_id":"NCT03561870","title":"Olaparib in Recurrent IDH-mutant Glioma","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06305910","title":"CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":24,"lead_sponsor_name":"OX2 Therapeutics","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}